FindTrial
Sign In

Three dimensional culture of solid tissue on microfluidic chip and a new method for in situ analysis of drug action

Three dimensional culture of solid tissue on microfluidic chip and a new method for in situ analysis of drug action

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055915
Enrollment
Unknown
Registered
2022-01-23
Start date
2022-01-24
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

In situ analysis group:none
Immunohistochemistry group:none

Sponsors

Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Glioma is consistent with the diagnostic criteria in the code for diagnosis and treatment of glioma (2018 Edition); 2. Headache, vomiting, decreased vision and other symptoms; 3. Patients or family members signed informed consent; 4. Vital signs are stable.

Exclusion criteria

Exclusion criteria: 1. Combined with other malignant tumors; 2. Mental illness and disturbance of consciousness; 3. Complicated with heart, liver, kidney and other organic diseases; 4. Infectious diseases; 5. Allergic to contrast media; 6. There are metal implants in the body.

Design outcomes

Primary

MeasureTime frame
Three dimensional co culture model;—

Secondary

MeasureTime frame
article;—

Countries

China

Contacts

Public ContactLin Caihou

Fujian Medical University Union Hospital

lincai76@163.com+86 15880686052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026